Why internationally adopted children should be screened for tuberculosis

Long, Richard; Boffa, Jody
July 2007
CMAJ: Canadian Medical Association Journal;7/17/2007, Vol. 177 Issue 2, p172
Academic Journal
The author discusses the importance of systematic screening for tuberculosis of the internationally adopted children in Canada. The author remarks that because pediatric tuberculosis is important medically and indicative of a public health problem, screening of international adoptees for tuberculosis is imperative in the country because most often these children comes from resource-poor countries where infectious diseases such as tuberculosis are common.


Related Articles

  • Preventing Infectious Diseases during and after International Adoption. Chen, Lin H.; Barnett, Elizabeth D.; Wilson, Mary E. // Annals of Internal Medicine;9/1/2003 Part 1, Vol. 139 Issue 5, p371 

    Families of internationally adopted children face risks associated with travel if they pick up their children overseas. Unlike other travelers, they also face risks because of close contact with a child with uncertain infection and vaccination status. Tuberculosis organisms, hepatitis A virus,...

  • Patient and health care system delays in the start of tuberculosis treatment in Norway. Farah, Mohamed Guled; Rygh, Jens Henning; Steen, Tore W.; Selmer, Randi; Heldal, Einar; Bjune, Gunnar // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p33 

    Background: Delay in start of tuberculosis (TB) treatment has an impact at both the individual level, by increasing the risk of morbidity and mortality, and at the community level, by increasing the risk of transmission. The aims of this study were to assess the delays in the start of treatment...

  • Integrating tuberculosis and HIV services. Whitelaw, A. // Southern African Journal of Epidemiology & Infection;2011, Vol. 26 Issue 2, p55 

    The tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics pose huge challenges to health services in South Africa. People with HIV infection are at significantly higher risk of both TB infection and progression to active disease. There is, thus, a need to implement adequate...

  • Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. Aiken, Alexander M; Hill, Philip C; Fox, Annette; McAdam, Keith PWJ; Jackson-Sillah, DollY; Lugos, Moses D; Donkor, Simon A; Adegbola, Richard A; and Roger H Brookes // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p66 

    Background: New tools are required to improve tuberculosis (TB) diagnosis and treatment, including enhanced ability to compare new treatment strategies. The ELISPOT assay uses Mycobacterium tuberculosis-specific antigens to produce a precise quantitative readout of the immune response to...

  • Vaccines for TB: Lessons from the Past Translating into Future Potentials. Tye, Gee Jun; Lew, Min Han; Choong, Yee Siew; Lim, Theam Soon; Sarmiento, Maria Elena; Acosta, Armando; Norazmi, Mohd Nor // Journal of Immunology Research;6/3/2015, Vol. 2015, p1 

    Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of...

  • Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia. Harper, M.; Ahmadu, F.A.; Ogden, J.A.; McAdam, K.P.; Lienhardt, C. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Sep2003, Vol. 97 Issue 5, p506 

    Abstract: Despite the availability of effective treatment, tuberculosis (TB) remains a major cause of death from an infectious disease in the world, particularly in resource-poor countries. Among the chief reasons for this are deficiencies in case tracing and in adherence to treatment. In order...

  • TB or not TB? Greenhalgh, Trisha // Accountancy;Aug2001, Vol. 128 Issue 1296, p56 

    This article focuses on the increasing incidents of tuberculosis in Great Britain as of 2001. One third of the world's entire population is currently infected, and 10,000 people die of the complications of tuberculosis every day. Dickensian conditions--urban squalor, overcrowding, poor...

  • Tuberculosis. Williams, David S. // Journal of Insurance Medicine;2008, Vol. 40 Issue 1, p72 

    Tuberculosis is the number one infectious disease killer worldwide: 2 billion people have latent TB, and 3 million people die of the disease annually.

  • Predominance of Ancestral Lineages of Mycobacterium tuberculosis in India. Gutierrez, M. Cristina; Ahmed, Niyaz; Willery, Eve; Narayanan, Sujatha; Hasnain, Seyed E.; Chauhan, Devendra S.; Katoch, Vishwa M.; Vincent, Véronique; Locht, Camille; Supply, Philip // Emerging Infectious Diseases;Sep2006, Vol. 12 Issue 9, p1367 

    Although India has the highest prevalence of tuberculosis (TB) worldwide, the genetic diversity of Mycobacterium tuberculosis in India is largely unknown. A collection of 91 isolates originating from 12 different regions spread across the country were analyzed by genotyping using 21 loci with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics